Published in J Surg Oncol on May 01, 2000
Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results. J Cancer Res Clin Oncol (2009) 1.34
Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. World J Gastroenterol (2008) 1.22
Peritoneal carcinomatosis. World J Gastroenterol (2013) 1.04
Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg (2006) 1.02
Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei. World J Gastroenterol (2008) 0.91
Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer. World J Surg (2004) 0.87
Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial. BMC Cancer (2015) 0.87
Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy. Cancer Manag Res (2012) 0.86
Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future. J Gastrointest Oncol (2016) 0.82
Efficacy of intraperitoneal thermochemotherapy and immunotherapy in intraperitoneal recurrence after gastrointestinal cancer resection. World J Gastroenterol (2002) 0.82
Intensive care unit admission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Is it necessary? J Oncol (2014) 0.81
Cytoreductive surgery combined with intraperitoneal chemohyperthermia for the treatment of advanced colon cancer. World J Surg (2006) 0.80
A prospective evaluation of venous thromboembolism in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Can J Surg (2009) 0.75
Peritonectomy for peritoneal carcinomatosis: long-term outcomes from a single Brazilian institution. World J Surg (2009) 0.75
Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer (1967) 3.04
Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer (1996) 1.92
Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol (2000) 1.92
Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr (1994) 1.89
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood (2000) 1.79
Effectiveness of continuous wound infusion of 0.5% ropivacaine by On-Q pain relief system for postoperative pain management after open nephrectomy. Br J Anaesth (2008) 1.70
Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration. Int J Radiat Oncol Biol Phys (1998) 1.68
Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol (2003) 1.64
Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. Br J Cancer (1993) 1.55
Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder. Ann Oncol (1999) 1.53
Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers. Am J Clin Pathol (1994) 1.52
Short- and long-term effects of 186Re-1,1-hydroxyethylidene diphosphonate in the treatment of painful bone metastases. J Nucl Med (2000) 1.47
Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res (1990) 1.43
Effects of isolated limb perfusion with tumor necrosis factor-alpha on circulating levels of proinflammatory cytokines. J Immunother (2001) 1.42
Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study. J Clin Oncol (1992) 1.42
Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res (1997) 1.42
Inflammatory aneurysm of the abdominal aorta. A prospective clinical study. J Cardiovasc Surg (Torino) (1999) 1.39
Partial trisomy 3p24.3 and partial monosomy 5p15.33: case report and a literature review. Genet Couns (2013) 1.38
Does low-molecular-weight heparin influence cancer-related mortality? Ann Oncol (2006) 1.38
Reversible corpus callosum lesion in legionnaires' disease. J Neurol Neurosurg Psychiatry (2004) 1.38
Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor. Int J Cancer (1992) 1.34
c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings. Am J Pathol (2001) 1.29
Changes in expression of alpha 6/beta 4 integrin heterodimer in primary and metastatic breast cancer. Br J Cancer (1992) 1.24
The effect of extend of caval resection in the treatment of inferior vena cava leiomyosarcoma. Anticancer Res (1998) 1.22
Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori (1999) 1.17
Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues. Int J Cancer (1991) 1.16
Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood (1999) 1.15
Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial. Neurology (2010) 1.15
Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine. Ann Oncol (2010) 1.14
Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys (2001) 1.12
MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children. J Clin Oncol (1997) 1.11
Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2. Int J Cancer (1999) 1.11
Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol (1998) 1.10
Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic model. Cancer (1989) 1.10
Local recurrence after curative resection for colorectal cancer: frequency, risk factors and treatment. J Surg Oncol Suppl (1991) 1.10
Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys (1998) 1.09
Prognostic relevance of altered Fas (CD95)-system in human breast cancer. Int J Cancer (2000) 1.08
Integrin expression in cutaneous malignant melanoma: association of the alpha 3/beta 1 heterodimer with tumor progression. Int J Cancer (1993) 1.07
Second generation monoclonal antibodies to the human integrin alpha 6 beta 4. Hybridoma (1990) 1.07
Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas. J Clin Oncol (1998) 1.06
The open ring. A new imaging sign in demyelinating disease. J Neuroimaging (1996) 1.06
Breast cancer is associated with loss of the c-kit oncogene product. Int J Cancer (1992) 1.05
CA 72-4 serum marker--a new tool in the management of carcinoma patients. Cancer Invest (1995) 1.05
Low-frequency stimulation enhances burst activity in cortical cultures during development. Neuroscience (2009) 1.05
The influence of tumor lymphocytic infiltration on long term survival of surgically treated colorectal cancer patients. Int Surg (1993) 1.04
Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer. Ann Oncol (2004) 1.04
Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells. J Natl Cancer Inst (1981) 1.02
Evaluation of a rapid immunochromatographic test for serodiagnosis of visceral leishmaniasis. Eur J Clin Microbiol Infect Dis (2002) 1.01
Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. J Am Coll Surg (1995) 1.01
Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells. Oncogene (2006) 1.00
Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years. Thyroid (2006) 0.99
Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol (2010) 0.99
Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. Clin Cancer Res (1999) 0.99
Distribution of laminin and collagen type-IV in benign and malignant lesions of melanocytic origin. Int J Cancer (1985) 0.99
Coloanal anastomosis for rectal cancer. Long-term results at the Mayo and Cleveland Clinics. Dis Colon Rectum (1995) 0.98
Toxic shock syndrome due to group C streptococci. A case report. Intensive Care Med (1996) 0.98
Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens. J Natl Cancer Inst (1984) 0.97
Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions. J Immunol (1983) 0.97
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis. Ann Oncol (2011) 0.97
Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion. Cancer (1989) 0.96
Spontaneous choroidal detachment and 'red-eyed shunt syndrome': two clinical entities with the same cause? Int Ophthalmol (1985) 0.95
Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer. Ann Oncol (2003) 0.95
EGF-R expression in ductal breast cancer: proliferation and prognostic implications. Anticancer Res (1997) 0.95
Immunohistochemical study of fatty acid synthase in ovarian neoplasms. Oncol Rep (2000) 0.95
Prognostic significance of flow cytometry in lung cancer. A 5-year study. Cancer (1987) 0.94
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort. Ann Oncol (2011) 0.94
P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: distribution and prognostic relevance. Eur J Cancer (2008) 0.94
In vitro cortical neuronal networks as a new high-sensitive system for biosensing applications. Biosens Bioelectron (2005) 0.94
S-100 and NSE as serum markers in melanoma. Acta Oncol (1997) 0.94
A simple microfluidic system for patterning populations of neurons on silicon micromachined substrates. J Neurosci Methods (1999) 0.93
Structure, function and gene expression of epithelial mucins. Tumori (1997) 0.93
The responsiveness of bone metastases to radiotherapy: the effect of site, histology and radiation dose on pain relief. Radiother Oncol (1989) 0.93
Astasia and gait failure with damage of the pontomesencephalic locomotor region. Ann Neurol (1994) 0.93
The biochemical mechanism of selective heat sensitivity of cancer cells. I. Studies on cellular respiration. Eur J Cancer (1969) 0.92
Extracellular recordings from locally dense microelectrode arrays coupled to dissociated cortical cultures. J Neurosci Methods (2008) 0.92
Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity. Mult Scler (2005) 0.91
Mechanical and morphological properties of living 3T6 cells probed via scanning force microscopy. Microsc Res Tech (1997) 0.91
Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy. J Cancer Res Clin Oncol (2000) 0.91
Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions. Br J Cancer (1995) 0.90
Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J Clin Endocrinol Metab (1998) 0.90
Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma. J Nucl Med (1997) 0.90
Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study. J Clin Oncol (1991) 0.90